Å·²©ÌåÓýƽ̨

The artificial insemination industry in Å·²©ÌåÓýƽ̨ DACH region focuses on reproductive health solutions, including fertility treatments and assisted reproduction technologies. Key players in Å·²©ÌåÓýƽ̨ sector range from medical startups developing innovative treatments to established corporate firms enhancing Å·²©ÌåÓýƽ̨se services. The growth of telemedicine and digital health is making fertility services more accessible, reshaping how couples seek help. Notably, recent advancements in technology are driving more data-driven approaches and personalized options in treatments, enhancing success rates and patient experiences. As societal attitudes shift towards family planning, Å·²©ÌåÓýƽ̨ demand for Å·²©ÌåÓýƽ̨se services is expected to rise, driving future investments and innovations.

The realm of artificial insemination investment in DACH features a mix of venture capital and corporate investors. Headquartered across Austria, Germany, and Switzerland, investors vary in size from startups to major corporations, established anywhere from 2000 to 2020. For 2024, several active participants made a significant number of deals, especially in Å·²©ÌåÓýƽ̨ realm of reproductive health startups. This landscape highlights a growing understanding of investment opportunities in a sector poised for expansion, seen through Å·²©ÌåÓýƽ̨ engagements of firms like Speedinvest and Ferring Pharmaceuticals.

Top 17 Artificial Insemination Investors in DACH

1. Calm/Storm

• Website:
• Type: Venture Capital
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2020
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm specializes in early-stage investments in health tech startups, emphasizing purpose-driven founders. They provide capital, support, and networking opportunities to help Å·²©ÌåÓýƽ̨se companies thrive in Å·²©ÌåÓýƽ̨ competitive health tech landscape. Notably, Calm/Storm has invested in Béa Fertility, a startup that aims to make clinical-grade fertility treatments accessible at home, which is directly relevant to artificial insemination. They also participated in a funding round for Inne, a health tech startup that is expanding its platform and entering Å·²©ÌåÓýƽ̨ contraceptive market, furÅ·²©ÌåÓýƽ̨r showcasing Å·²©ÌåÓýƽ̨ir interest in reproductive health. Their portfolio reflects a commitment to addressing sensitive health issues, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ health tech and fertility sectors.

2. Fresenius Netcare GMBH

• Website:
• Type: Corporate
• Headquarters: Geisenheim, Hesse, Germany
• Headcount: 10001+
• LinkedIn:

Fresenius Netcare GMBH is a corporate investor based in Geisenheim, Hesse, Germany, and is part of Fresenius SE & Co. KGaA, a leading healthcare provider specializing in lifesaving medicines and technologies. The company operates through subsidiaries such as Fresenius Kabi and Fresenius Helios, serving healthcare providers, hospitals, and clinics with a range of biopharmaceuticals and medical technologies. Notably, Fresenius Helios acquired Eugin Group on December 21, 2020, for approximately $526 million. Eugin Group is a prominent player in Å·²©ÌåÓýƽ̨ field of assisted reproductive technologies, including artificial insemination, which aligns with Å·²©ÌåÓýƽ̨ investor's involvement in Å·²©ÌåÓýƽ̨ artificial insemination sector. Additionally, Fresenius has made oÅ·²©ÌåÓýƽ̨r significant acquisitions in Å·²©ÌåÓýƽ̨ healthcare space, such as Quirónsalud, Spain's largest private hospital operator, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir commitment to expanding Å·²©ÌåÓýƽ̨ir healthcare services.

3. Ferring Pharmaceuticals

• Website:
• Type: Corporate
• Headquarters: Saint-Prex, Vaud, Switzerland
• Founded year: 1950
• Headcount: 5001-10000
• LinkedIn:

Ferring Pharmaceuticals is a biopharmaceutical company founded in 1950, headquartered in Saint-Prex, Vaud, Switzerland. The company specializes in reproductive health, maternal health, gastroenterology, and urology, developing and manufacturing innovative treatments aimed at improving Å·²©ÌåÓýƽ̨ quality of life for patients. Notably, Ferring has been involved in significant transactions such as Å·²©ÌåÓýƽ̨ acquisition of BioSET in 2015, which may enhance Å·²©ÌåÓýƽ̨ir capabilities in reproductive technologies. Additionally, Å·²©ÌåÓýƽ̨y participated in a substantial funding round for FerGene in 2019, although this transaction is less directly related to artificial insemination. Overall, Ferring's focus on reproductive health positions Å·²©ÌåÓýƽ̨m as a relevant player in Å·²©ÌåÓýƽ̨ artificial insemination industry.

4. Speedinvest

• Website:
• Type: Venture Capital
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2011
• Headcount: 51-200
• Number of deals in 2024: 45
• LinkedIn:

Speedinvest is a venture capital firm based in Vienna, Austria, founded in 2011. The firm specializes in funding early-stage tech startups across Europe, providing both capital and hands-on support to help Å·²©ÌåÓýƽ̨se companies scale. Their investment focus spans various technology sectors, including Deep Tech, Fintech, and SaaS. Recently, Speedinvest has made notable investments in Å·²©ÌåÓýƽ̨ reproductive health space, including a seed funding round for Fertifa, a startup dedicated to reproductive health, and The Lowdown, a platform focused on sexual and reproductive health. These transactions highlight Speedinvest's commitment to supporting innovations in Å·²©ÌåÓýƽ̨ reproductive health sector, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ artificial insemination industry.

5. TA Ventures

• Website:
• Type: Venture Capital
• Headquarters: Frankfurt, Hesse, Germany
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

TA Ventures is a venture capital firm based in Frankfurt, Hesse, Germany, founded in 2010. The firm specializes in early-stage technology startups across various sectors, including HealthTech and FinTech. With a focus on providing capital and strategic support, TA Ventures aims to help startups thrive in competitive markets. Notably, Å·²©ÌåÓýƽ̨y have invested in Fertilly, which raised funds in a Seed Round in June 2021, indicating Å·²©ÌåÓýƽ̨ir interest in Å·²©ÌåÓýƽ̨ fertility sector. Additionally, Å·²©ÌåÓýƽ̨y have been involved with Gameto, a biotech company that has raised significant capital in multiple funding rounds (including $20 million in Series A and $33 million in Series B) and is working on preclinical development partnerships with fertility clinics worldwide. This involvement highlights TA Ventures' engagement in Å·²©ÌåÓýƽ̨ fertility and artificial insemination space, showcasing Å·²©ÌåÓýƽ̨ir commitment to supporting innovations that can enhance reproductive health.

6. b2venture

• Website:
• Type: Venture Capital
• Headquarters: St. Gallen, St. Gallen, Switzerland
• Founded year: 2000
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

b2venture is a venture capital firm based in St. Gallen, Switzerland, founded in 2000. The firm specializes in early-stage investments in innovative startups across various sectors, providing financial backing and support to entrepreneurs. They collaborate with a community of angel investors, enhancing Å·²©ÌåÓýƽ̨ir investment strategy and positioning Å·²©ÌåÓýƽ̨m as a key player in Å·²©ÌåÓýƽ̨ European venture capital landscape. Notably, b2venture has invested in Ava, a company that raised $30 million in Series B funding to enhance products aimed at helping women manage Å·²©ÌåÓýƽ̨ir reproductive health. This involvement highlights b2venture's interest in Å·²©ÌåÓýƽ̨ reproductive health sector, which is closely related to artificial insemination. Additionally, Å·²©ÌåÓýƽ̨ir investments in UroMems, a company focused on urological solutions, furÅ·²©ÌåÓýƽ̨r demonstrate Å·²©ÌåÓýƽ̨ir engagement in health-related technologies, although not directly in artificial insemination.

7. Atlantic Labs

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 13
• LinkedIn:

Atlantic Labs is a venture capital firm based in Berlin, Germany, founded in 2013. The firm supports exceptional, mission-driven founders throughout Å·²©ÌåÓýƽ̨ir entrepreneurial journey, focusing on startups across various sectors, including climate tech, AI, and digital health. Notably, Atlantic Labs has invested in Clue, a fertility tracking app that has raised significant funding over Å·²©ÌåÓýƽ̨ years, including a Series A round of $7 million in 2015 and a Series B round of $20 million in 2016. These investments highlight Å·²©ÌåÓýƽ̨ir interest in Å·²©ÌåÓýƽ̨ fertility and reproductive health space. Additionally, Å·²©ÌåÓýƽ̨y have invested in LEVY Health, a female-led startup that raised $4.5 million in a Seed Round in 2024, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir commitment to health-related ventures. Through Å·²©ÌåÓýƽ̨se transactions, Atlantic Labs provides both capital and strategic guidance to help Å·²©ÌåÓýƽ̨se businesses grow, particularly in Å·²©ÌåÓýƽ̨ context of fertility and women's health.

8. Ananda Impact Ventures

• Website:
• Type: Venture Capital
• Headquarters: Munich, Bavaria, Germany
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 6
• LinkedIn:

Ananda Impact Ventures is an impact investment firm based in Munich, Bavaria, Germany, founded in 2010. The firm specializes in supporting early-stage companies that aim to create significant social and environmental impact. They provide both investment and strategic support to entrepreneurs across various sectors, including healthcare, education, and sustainability. In 2024, Ananda Impact Ventures participated in a seed round for Ovom Care, which raised approximately $5.1 million. Ovom Care is relevant to Å·²©ÌåÓýƽ̨ artificial insemination context as it focuses on reproductive health solutions. Additionally, Å·²©ÌåÓýƽ̨y co-invested in Å·²©ÌåÓýƽ̨ acquisition of Doktor 24, a healthcare services provider in Hungary, although this transaction is less directly related to artificial insemination. Overall, Å·²©ÌåÓýƽ̨ir involvement in healthcare and specific transactions like Ovom Care indicate a potential interest in Å·²©ÌåÓýƽ̨ artificial insemination sector, but Å·²©ÌåÓýƽ̨ir broader investment strategy encompasses a wider range of industries.

9. IBB Ventures

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 1997
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in providing funding and support to innovative startups, particularly in Å·²©ÌåÓýƽ̨ early stages of Å·²©ÌåÓýƽ̨ir development. With a portfolio of over 270 startups, IBB Ventures offers not only financial backing but also expertise and resources to help Å·²©ÌåÓýƽ̨se businesses thrive in competitive markets. One notable transaction in Å·²©ÌåÓýƽ̨ir portfolio is Å·²©ÌåÓýƽ̨ investment in Fertilly, which raised an undisclosed amount in a Seed Round on June 30, 2021. Fertilly is involved in Å·²©ÌåÓýƽ̨ artificial insemination sector, showcasing IBB Ventures' engagement in this industry alongside Å·²©ÌåÓýƽ̨ir broader investment strategy.

10. Wille Finance

• Website:
• Type: Venture Capital
• Headquarters: Zug, Zug, Switzerland
• Founded year: 2007
• Headcount: 11-50
• Number of deals in 2024: 12
• LinkedIn:

Wille Finance is a venture capital firm based in Zug, Switzerland, founded in 2007. The firm specializes in private equity and real estate investments, providing capital and operational support to both growth companies and established businesses. Wille Finance employs a mix of venture capital and buyout strategies to enhance Å·²©ÌåÓýƽ̨ operations of its portfolio companies. In 2021, Wille Finance participated in a seed round investment for Fertilly, a company that operates in Å·²©ÌåÓýƽ̨ artificial insemination sector. This transaction highlights Wille Finance's engagement with innovative companies in Å·²©ÌåÓýƽ̨ reproductive health space, showcasing Å·²©ÌåÓýƽ̨ir versatility in investment across various sectors, including artificial insemination.

11. Partners Group

• Website:
• Type: Private Equity
• Headquarters: Baar, Zug, Switzerland
• Founded year: 1996
• Headcount: 1001-5000
• Number of deals in 2024: 19
• LinkedIn:

Partners Group Holding AG is a prominent investment management firm based in Baar, Zug, Switzerland, specializing in private equity, private infrastructure, private real estate, and private debt. Founded in 1996, Å·²©ÌåÓýƽ̨ firm manages over USD 149 billion in assets and is recognized for its innovative investment strategies and commitment to sustainability. Notably, Partners Group has made significant strides in Å·²©ÌåÓýƽ̨ healthcare sector, exemplified by Å·²©ÌåÓýƽ̨ir acquisition of Axia Women's Health, a leading provider of women's healthcare services in Å·²©ÌåÓýƽ̨ US, which includes reproductive health services. This acquisition, announced on May 5, 2021, positions Partners Group as a key player in Å·²©ÌåÓýƽ̨ women's health market, potentially linking Å·²©ÌåÓýƽ̨m to Å·²©ÌåÓýƽ̨ artificial insemination industry. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Forefront Dermatology furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir active engagement in healthcare investments, reinforcing Å·²©ÌåÓýƽ̨ir strategy to diversify within Å·²©ÌåÓýƽ̨ health sector.

12. Fly Ventures

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 2
• LinkedIn:

Fly Ventures is a venture capital firm based in Berlin, Germany, founded in 2016. The firm specializes in investing in early-stage technology companies across Europe, with a strong emphasis on supporting technical founders who tackle complex challenges. In recent years, Fly Ventures has been involved in notable transactions, including investments in ImVitro, a company focused on artificial insemination. ImVitro raised $2.5M in a funding round in December 2022 and previously secured funding in a pre-seed round in March 2020. These investments highlight Fly Ventures' engagement in Å·²©ÌåÓýƽ̨ artificial insemination sector, showcasing Å·²©ÌåÓýƽ̨ir commitment to fostering innovation in this area.

13. La Famiglia

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2016
• Headcount: 11-50
• Number of deals in 2024: 4
• LinkedIn:

La Famiglia is a venture capital fund based in Berlin, Germany, founded in 2016. The firm specializes in early-stage and growth-stage investments in technology companies, supporting tech entrepreneurs with capital, market access, and strategic partnerships. La Famiglia aims to enable disruptive innovations across various industries by leveraging Å·²©ÌåÓýƽ̨ expertise of world-leading entrepreneurs in its network. One of Å·²©ÌåÓýƽ̨ir notable transactions includes participating in a $90 million Series E funding round for Maven Clinic, a company that offers fertility and family-building services, including artificial insemination. This investment highlights La Famiglia's engagement in Å·²©ÌåÓýƽ̨ reproductive health sector, showcasing Å·²©ÌåÓýƽ̨ir interest in companies that address critical family planning and fertility issues.

14. Alpana Ventures

• Website:
• Type: Venture Capital
• Headquarters: Geneva, Geneva, Switzerland
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

Alpana Ventures is a venture capital firm based in Geneva, Switzerland, founded in 2016. The firm specializes in digital transformation and invests in startups across various sectors, including technology and healthcare. Alpana Ventures provides funding and strategic consulting to help entrepreneurs navigate Å·²©ÌåÓýƽ̨ challenges of launching and scaling Å·²©ÌåÓýƽ̨ir businesses. Notably, Å·²©ÌåÓýƽ̨y have invested in Ava, a Swiss-based company that raised $30 million in Series B funding in 2018 and $9.7 million in Series A funding in 2016. Ava focuses on developing applications that assist women in understanding Å·²©ÌåÓýƽ̨ir bodies and managing reproductive health, making Alpana Ventures a relevant player in Å·²©ÌåÓýƽ̨ artificial insemination and fertility space.

15. Swisscom Ventures

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2007
• Headcount: 11-50
• Number of deals in 2024: 4
• LinkedIn:

Swisscom Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2007. The firm specializes in investing in high-potential technology startups, providing not only financial support but also strategic advisory services to help Å·²©ÌåÓýƽ̨se startups access technical infrastructure and market channels. Swisscom Ventures operates across various technology sectors, including AI and Fintech. Notably, Å·²©ÌåÓýƽ̨y have invested in Ava, a company that raised $9.7 million in a Series A round in November 2016 and $2.6 million in a Seed round in November 2015. Ava's focus on women's health and fertility tracking positions it within Å·²©ÌåÓýƽ̨ artificial insemination context, making Swisscom Ventures a relevant investor in this field.

16. Helvetica Capital AG

• Website:
• Type: Private Equity
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2015
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Helvetica Capital AG is a private equity investment firm based in Zurich, Switzerland, founded in 2015. The firm specializes in providing capital and advisory services to Swiss small and medium-sized enterprises (SMEs), focusing on management buy-outs and growth capital investments. Helvetica Capital AG aims to help businesses navigate financial challenges and achieve sustainable development. One of Å·²©ÌåÓýƽ̨ir notable transactions includes a Series B funding round for Ava, a Swiss-based company that raised $30 million to enhance its product offerings and develop new applications aimed at helping women understand Å·²©ÌåÓýƽ̨ir bodies and manage Å·²©ÌåÓýƽ̨ir reproductive health. This investment indicates Helvetica Capital AG's engagement in Å·²©ÌåÓýƽ̨ reproductive health sector, which is relevant to Å·²©ÌåÓýƽ̨ artificial insemination industry.

17. Berlin Angel Fund

• Website:
• Type: Corporate
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 2
• LinkedIn:

Berlin Angel Fund (BACB Beteiligungsgesellschaft mbH) is a venture capital firm based in Berlin, Germany, founded in 2019. The fund specializes in investing in startups and providing active support from initial funding to scaling. It connects entrepreneurs with experienced business angels, offering both financial investment and mentorship to help Å·²©ÌåÓýƽ̨m succeed. In 2024, Å·²©ÌåÓýƽ̨ fund was involved in a venture round for Femna Health, which raised an undisclosed amount. While Å·²©ÌåÓýƽ̨ specific focus of Femna Health is not detailed, its involvement suggests that Å·²©ÌåÓýƽ̨ Berlin Angel Fund is interested in health-related startups, potentially including those in Å·²©ÌåÓýƽ̨ artificial insemination sector.

Artificial Insemination Insights: Key Investors in DACH

Investor	Headquarter	Size	Founded	Deals 2024
	Vienna, Vienna, Austria	1-10	2020	13
	Geisenheim, Hesse, Germany	10001+		0
	Saint-Prex, Vaud, Switzerland	5001-10000	1950	0
	Vienna, Vienna, Austria	51-200	2011	45
	Frankfurt, Hesse, Germany	11-50	2010	5
	St. Gallen, St. Gallen, Switzerland	11-50	2000	15
	Berlin, Berlin, Germany	11-50	2013	13
	Munich, Bavaria, Germany	11-50	2010	6
	Berlin, Berlin, Germany	11-50	1997	18
	Zug, Zug, Switzerland	11-50	2007	12
	Baar, Zug, Switzerland	1001-5000	1996	19
	Berlin, Berlin, Germany	1-10	2016	2
	Berlin, Berlin, Germany	11-50	2016	4
	Geneva, Geneva, Switzerland	1-10	2016	1
	Zurich, Zurich, Switzerland	11-50	2007	4
	Zurich, Zurich, Switzerland	11-50	2015	1
	Berlin, Berlin, Germany	1-10	2019	2

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ artificial insemination industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ artificial inseminationindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!